After adjusting for confounders including age, sex, comorbidities (HP, DM, CLD, CHD, CKD, COPD, stroke, and cancer), and disease severity indicators (hs-CRP, D-dimer, NEU) in a multivariate Cox model, the HRs for risk of mortality with increased early levels of hs-TnI, CK-MB, and MYO were 2.31 (95% CI, 1.20-4.48, p = 0.013), 1.82 (95% CI, 1.01-3.31, p = 0.048), and 8.31 (95% CI, 3.94-17.52, p < 0.001), respectively. This evidence concerns the gene CRP and cancer.